Inc. Magazine Spotlights Rainier Clinical Research Center as one of their Fastest Growing Companies in the United States

Inc. names RCRC one of the fastest growing companies in the US.

Rainier Clinical Research Center (RCRC) is excited to announce that we have been recognized by Inc. Magazine on their “Inc. 5000” list as one of their fastest growing privately held companies in the United States. The publication highlighted that RCRC offers a dedicated clinical trial investigative site conducting medical device and biopharmaceutical clinical trials, and reports that the Center has experienced 23% growth over the most recent three years of operations.

RCRC is proud of this national recognition that demonstrates that we are making a meaningful impact in the health and medical sector as well as in the broader business marketplace. We continue to be committed to delivering consistent, high-quality research, building a team that is passionate about our work, and creating long-term partnerships with our sponsors, partners, and research participants.

Every honoree was required to pass Inc.’s editorial review. One essential factor weighed during this editorial review is that “companies must meet standard editorial guidelines, which emphasize accuracy, fairness, transparency, and ethics.”  Inc.’s editorial staff further conveyed that honorees, “…leveraged their core strengths to drive remarkable outcomes, navigating challenges along the way, including economic uncertainty, rapid innovation, and political uncertainty.” Our team can take great pride in the fact that their work has been essential to achieving these goals.

We believe this recognition will serve to bolster our commitment to continuing our thoughtful growth, to investing in our team members, and to expanding how we serve our clients.